Enveric Biosciences, Inc. (ENVB) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Enveric Biosciences, Inc.

ENVB

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4M

Biotechnology

Next Earning date - 11 Nov 2024

4M

Biotechnology

Next Earning date - 11 Nov 2024

0.50USD

-0.03 ( -5.86%)

Relative Strenght

12

Volume Buzz

-89%

Earning Acce

Yes

Dist 52w H.

83%

Quote Panel

Updated October 26, 2024

1W -5.93 % 1M 4.52 % 3M 1.63 % 1Y -71.88 %

Key Metrics

Market Cap
4.47M
Shares Outstanding
8.92M
Share in Float
8.05M
Dividende
0

Earning Date
11 Nov 2024
Price Target
0.501
Average Volume
1.39M
Beta
0.501

Range
0.361-2.92
Industry
Biotechnology
Website
https://www.enveric.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

7.34x

P/S Ratio

0.75x

P/B Ratio

0.0

Debt/Equity

-1637.2%

Net Margin

$-3.5

EPS

How ENVB compares to sector?

P/E Ratio

Relative Strength

ENVB

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$10M

NaN%

2025-Revenue

$1.41

-464%

2025-EPS

$8M

530%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-1.46
vs -6.00

Q4.22

N/A

-6.76
vs -90.97

Q1.23

N/A

-2.22
vs -5.50

Q2.23

N/A

-3.04
vs -2.73

Q3.23

N/A

-1.30
vs -1.46

Q4.23

N/A

-1.46
vs -6.76

Q1.24

N/A

-0.61
vs -2.22

Q2.24

N/A

-0.25
vs -3.04

Q3.24

N/A

-0.52
vs -1.30

Q4.24

N/A

-0.40
vs -1.46

Sales Growth

YoY

Current

Estimates

Q1.22

NA

NA vs NA

Q2.22

NA

NA vs NA

Q3.22

NA

NA vs NA

Q4.22

NA

NA vs NA

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

647.1K vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Return on Equity

QoQ

Q3.22

+3%

0.03
vs -0.04

Q4.22

-96%

-0.96
vs 0.03

Q1.23

-44%

-0.44
vs -0.96

Q2.23

-131%

-1.31
vs -0.44

Q3.23

-116%

-1.16
vs -1.31

Q4.23

-91%

-0.91
vs -1.16

Q1.24

-38%

-0.38
vs -0.91

Q2.24

-35%

-0.35
vs -0.38

Institutionnal Ownership

QoQ

Q3.22

8

8
vs 1

700%

Q4.22

10

10
vs 8

25%

Q1.23

12

12
vs 10

20%

Q2.23

14

14
vs 12

17%

Q3.23

14

14
vs 14

NA

Q4.23

14

14
vs 14

NA

Q1.24

17

17
vs 14

21%

Q2.24

17

17
vs 17

NA

Earnings Growth

Latest News

ENVB

investorplace.com

7 hours ago

Why Is Enveric Biosciences (ENVB) Stock Up 18% Today?

ENVB

businesswire.com

8 hours ago

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop

ENVB

businesswire.com

8 hours ago

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

ENVB

globenewswire.com

8 hours ago

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

ENVB

businesswire.com

8 hours ago

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate

ENVB

businesswire.com

17 hours ago

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results

New Feature Coming Soon, Stay Tuned!

Shape

Shape